Lb Pharmaceuticals INC (LBRX) — S-1 Filings
All S-1 filings from Lb Pharmaceuticals INC. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
LB Pharmaceuticals Eyes Nasdaq Debut with Phase 3-Ready Schizophrenia Drug
— Aug 22, 2025 Risk: high
LB Pharmaceuticals Inc. (LBRX) is a clinical-stage biopharmaceutical company focused on neuropsychiatric diseases, filing an S-1 for its initial public offering
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX